Loading clinical trials...

TB-CAPT MTB/XDR Study | Clinical Trials | Clareo Health

Active Not RecruitingNCT04567368

TB-CAPT MTB/XDR Study

The Cepheid Xpert MTB/XDR cartridge, which runs on the same platform as Xpert MTB/RIF Ultra, has been developed to detect additional resistance to isoniazid, fluoroquinolones and second-line injectabl...

Lead sponsor: Foundation for Innovative New Diagnostics, Switzerland•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Artificial Intelligence for Highly Myopic Cataract

NCT06616506 · Cataract, High Myopia, and more

RECRUITINGNA

Rapid Research in Diagnostics Development for TB Network

NCT04923958 · Tuberculosis

RECRUITINGNA

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

NCT06590428 · Rifampin-resistant Tuberculosis, Drug-resistant Tuberculosis

RECRUITINGPhase 2

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

NCT06192160 · Pulmonary Tuberculosis

RECRUITINGPhase 2

Evaluating the Safety and Immunogenicity of MTBVAC

NCT05947890 · HIV I Infection, Tuberculosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 1, 2024Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment753

Start dateMay 2021

Last updatedOct 1, 2024

Condition

Tuberculosis Resistance Bacterial Diagnoses Disease

Locations shown

University of Cape Town

Cape Town

University of the Witwatersrand

Johannesburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 1, 2024Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions